Translation and Validation of the COMM and ASI-SR

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Opioid UseOpioid Use DisorderAlcohol Use DisorderPain, Chronic
Interventions
DIAGNOSTIC_TEST

Current Opioid Misuse Measure (COMM)-SWE

Patients in test group should fulfill the the COMM and the battery of validation forms as well as leave the oral fluid for illicit drugs test and whole blod for phosphatidylethanol test.

DIAGNOSTIC_TEST

Oral fluid drug test

Oral fluid sampling to detect drugs. Analysis with LC-HRMS

DIAGNOSTIC_TEST

PETh

Alcohol use detection

DIAGNOSTIC_TEST

ASI-SR

Cross-validation form

DIAGNOSTIC_TEST

AUDIT

Cross-validation form

DIAGNOSTIC_TEST

DUDIT

Cross-validation form

DIAGNOSTIC_TEST

Brief Pain Inventory - BPI

Cross-validation form

DIAGNOSTIC_TEST

Patient Global Impression of Change PGIC

Cross-validation form

DIAGNOSTIC_TEST

GAD-7

Cross-validation form

DIAGNOSTIC_TEST

Patient Health questionnaire (PHQ9)

Cross-validation form

DIAGNOSTIC_TEST

DBS - cannabis test

cross-validation form

OTHER

Sample of Blood for later DNA and immunological analysis in future studies

sample collection for future studies

Trial Locations (1)

75185

RECRUITING

Multidisciplinary Pain Center, Uppsala

All Listed Sponsors
collaborator

The Kamprad Family Foundation for Entrepreneurship, Research & Charity

OTHER

lead

Uppsala University

OTHER